Home » New Patent Signals Faster Disease Diagnostics
New Patent Signals Faster Disease Diagnostics
February 3, 2005
Accelr8 Technology has been awarded U.S. Patent 6,844,028 for its OptiChem surface chemistry, a new coating that makes it possible to selectively capture, target and analyze individual bacteria, thus setting a new standard in rapid bacterial pathogen analysis. OptiChem is a component of the company's new BACcelr8r diagnostic system that, when fully developed, has the potential to replace bacterial culturing by producing test results in a matter of hours.
Yahoo News (http://biz.yahoo.com/prnews/050202/law066_1.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct